MedTrace Logo

Adult Trauma Centers RE-AIM at Gun Safety

NCT06302452 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1776

Last updated 2026-03-09

No results posted yet for this study

Summary

The goal of this interventional study is to evaluate the implementation and effectiveness of a comprehensive a universal firearm injury prevention program, ACTFAST (Adopting Comprehensive Training for FireArm Safety in Trauma centers), in level 1 trauma centers. The main aims of the study are:

1. (Primary Aim 1) Increase the adoption, implementation, and maintenance of a universal firearm injury prevention intervention at three participating trauma centers in the mid-Atlantic states;
2. (Primary Aim 2) Assess firearm injury prevention knowledge, attitudes, and safe storage practices among trauma patients treated within participating trauma centers.

Conditions

  • Firearm Injury
  • Safety Issues

Interventions

BEHAVIORAL

Adopting Comprehensive Training for FireArm Safety in Trauma Centers

Firearm access screening, brief firearm safe storage intervention, and referral to community and preventive health resources

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Rhode Island Hospital

    collaborator OTHER

  • WellSpan Health

    collaborator OTHER

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Katherine Hoops, MD, MPH · Johns Hopkins University

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-30
Primary Completion
2028-03-01
Completion
2028-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06302452 on ClinicalTrials.gov